In the present study, we found that pomiferin treatment could alleviate the severity of acute respiratory distress syndrome by blocking inflammation and oxidative stress in an AKT-dependent manner (Figure 9). This evidence concerns the gene AKT1 and acute respiratory distress syndrome.